MYGN
Myriad Genetics Inc
4.00$
+0.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.1% | 37.0% | 35.7% | 25.0% | 27.9% | 22.3% | 27.4% | 36.7% | 22.9% | 27.4% | 29.0% | 47.1% | |
| 7.9% | 8.4% | 7.8% | 8.5% | 9.4% | 6.0% | 8.2% | 19.5% | 4.7% | 11.5% | 10.0% | 21.2% | |
| 22.6% | 18.9% | 18.1% | 12.5% | 15.4% | 8.8% | 10.6% | 25.7% | 9.6% | 12.3% | 10.0% | 21.2% | |
| 10.3% | 11.4% | 10.8% | 7.9% | 8.8% | 8.9% | 6.3% | 6.9% | 8.5% | 10.0% | 11.8% | 16.3% | |
| 2.9% | 3.3% | 4.3% | 3.5% | 2.9% | 2.0% | 1.9% | 1.2% | 1.7% | 1.9% | 2.7% | 4.3% | |
| 20.5% | 23.1% | 22.2% | 26.1% | 27.1% | 26.7% | 23.2% | 18.1% | 23.9% | 25.1% | 27.9% | 7.3% | |
| 24.9% | 25.1% | 25.8% | 40.7% | 38.7% | 43.8% | 40.8% | 30.6% | 31.7% | 30.5% | 25.5% | 21.7% | |
| 12.7% | 13.6% | 15.0% | 36.5% | 17.8% | 30.3% | 37.9% | 26.7% | 26.1% | 31.7% | 31.8% | 47.9% | |
| 9.8% | 9.0% | 8.2% | 18.0% | 8.7% | 7.5% | 10.3% | 15.5% | 11.4% | 13.6% | 16.0% | 18.9% | |
| – | – | – | 5.4% | 5.8% | 5.0% | 1.0% | 1.0% | 1.2% | 1.4% | 1.2% | 1.0% | |
| 2.8% | 2.8% | 2.4% | 1.8% | 2.2% | 2.1% | 1.4% | 2.2% | 2.4% | 2.3% | 3.1% | 4.2% | |
| – | – | – | – | – | 14.4% | – | – | – | 3.4% | 3.9% | 17.0% | |
| 87.3% | 86.4% | 85.0% | 63.6% | 82.2% | 69.7% | 62.1% | 73.3% | 73.9% | 68.3% | 68.2% | 52.1% | |
| 0.2% | -10.0% | -8.3% | -6.5% | 4.6% | 1.6% | -16.0% | -19.2% | -30.5% | -54.9% | -73.6% | -158.9% | |
| 9.5% | 9.7% | 8.3% | 5.7% | 6.1% | 4.9% | 5.3% | 5.9% | 6.7% | 7.2% | 8.8% | 13.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.